Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661b3ea63e73acc96731eb73625b1bc2 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
filingDate |
2013-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09915485704ffddf26c1f098bf3eba5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6273b7fa53efea70ab46d8a891f999be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbe80e9f9fb42543502120020ed613aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e82cd093034951a31118cb7af80000d |
publicationDate |
2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2013257445-B2 |
titleOfInvention |
Conserved HBV and HCV sequences useful for gene silencing |
abstract |
Conserved consensus sequences from known hepatitis B virus strains and known hepatitis C virus strains, which are useful in inhibiting the expression of the viruses in 5 mammalian cells, are provided. These sequences are useful to silence the genes of HBV and HCV, thereby providing therapeutic utility against HBV and HCV viral infection in humans. |
priorityDate |
2004-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |